[HTML][HTML] A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009
W De, K Changwen, L Wei, C Monagin, Y Jin… - Archives of …, 2011 - Springer
A large outbreak of hand, foot and mouth disease (HFMD) occurred in Guangdong, China, in
2009. A total of 92,749 cases were officially reported to the Center for Disease Control and …
2009. A total of 92,749 cases were officially reported to the Center for Disease Control and …
[PDF][PDF] A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS
L Dai, T Zheng, K Xu, Y Han, L Xu, E Huang, Y An… - Cell, 2020 - cell.com
Vaccines are urgently needed to control the ongoing pandemic COVID-19 and previously
emerging MERS/SARS caused by coronavirus (CoV) infections. The CoV spike receptor-…
emerging MERS/SARS caused by coronavirus (CoV) infections. The CoV spike receptor-…
[PDF][PDF] Genomic epidemiology of SARS-CoV-2 in Guangdong province, China
…, W Li, J Su, H Zheng, B Peng, S Fang, W Su, K Li… - Cell, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2 infection and was first
reported in central China in December 2019. Extensive molecular surveillance in Guangdong, …
reported in central China in December 2019. Extensive molecular surveillance in Guangdong, …
[HTML][HTML] Comparison of nonhuman primates identified the suitable model for COVID-19
…, J Li, H Wang, H Long, J Zhou, F Luo, K Ding… - Signal transduction and …, 2020 - nature.com
Identification of a suitable nonhuman primate (NHP) model of COVID-19 remains
challenging. Here, we characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
challenging. Here, we characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
…, Y Gu, B Liu, Y Xu, C Li, W Pan, J Zhao, C Ke… - Nature …, 2020 - nature.com
The rapid spread of coronavirus SARS-CoV-2 greatly threatens global public health but no
prophylactic vaccine is available. Here, we report the generation of a replication-incompetent …
prophylactic vaccine is available. Here, we report the generation of a replication-incompetent …
[HTML][HTML] Prolonged persistence of SARS-CoV-2 RNA in body fluids
…, F Cui, Z Liu, J Lu, J Tian, W Ma, C Ke - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
We prospectively assessed 49 coronavirus disease cases in Guangdong, China, to estimate
the frequency and duration of detectable severe acute respiratory syndrome coronavirus 2 …
the frequency and duration of detectable severe acute respiratory syndrome coronavirus 2 …
[HTML][HTML] Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR
…, L du Plessis, T Song, W Ma, J Sun, OG Pybus, C Ke - …, 2020 - thelancet.com
Background Some COVID-19 cases test positive again for SARS-CoV-2 RNA following
negative test results and discharge, raising questions about the meaning of virus detection. …
negative test results and discharge, raising questions about the meaning of virus detection. …
Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates
…, Q Zhong, M Xu, NS Zhong, YX Zeng, GK Feng, C Ke… - ACS …, 2021 - ACS Publications
The coronavirus disease pandemic of 2019 (COVID-19) caused by the novel SARS-CoV-2
coronavirus resulted in economic losses and threatened human health worldwide. The …
coronavirus resulted in economic losses and threatened human health worldwide. The …
[HTML][HTML] Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
…, S Chen, M Jiang, L Feng, L Chen, C Lei, C Ke… - Nature …, 2021 - nature.com
SARS-CoV-2 vaccination has been launched worldwide to build effective population-level
immunity to curb the spread of this virus. The effectiveness and duration of protective immunity …
immunity to curb the spread of this virus. The effectiveness and duration of protective immunity …
Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significance
…, G Zeng, X Ren, H Li, C Ke, Y Tan, C Cai, K Lai… - …, 2006 - Wiley Online Library
Background: Severe acute respiratory syndrome (SARS) is a newly discovered disease
caused by a novel coronavirus. The present study studied the longitudinal profile of antibodies …
caused by a novel coronavirus. The present study studied the longitudinal profile of antibodies …